The average price target for vTv Therapeutics is 54.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $67.00 ,the lowest forecast is $44.00. The average price target represents 42.18% Increase from the current price of $38.12.